Published in Mol Cell Biol on July 01, 1988
Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci U S A (1992) 1.24
Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Mol Cell Biol (1993) 1.16
Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol (1996) 1.02
The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc Natl Acad Sci U S A (1998) 0.96
BALB/c-3T3 fibroblasts resistant to growth inhibition by beta interferon exhibit aberrant platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor signal transduction. Mol Cell Biol (1991) 0.82
Induction of protein-tyrosine-phosphatase activity by interleukin 6 in M1 myeloblastic cells and analysis of possible counteractions by the BCR-ABL oncogene. Proc Natl Acad Sci U S A (1993) 0.78
Stress induced experimental colitis. Mediators Inflamm (1993) 0.77
An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture. J Clin Invest (1998) 0.77
Inhibitory effect of interferon-beta on mouse spleen-derived mast cells. Mediators Inflamm (1993) 0.75
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell (1983) 17.87
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (1986) 7.19
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell (1984) 6.71
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
Translocations among antibody genes in human cancer. Science (1983) 6.20
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80
Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell (1984) 5.61
Viral oncogenes. Cell (1985) 5.20
Hereditary cancer, oncogenes, and antioncogenes. Cancer Res (1985) 5.12
Growth factors: mechanism of action and relation to oncogenes. Cell (1984) 4.80
Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (1984) 4.29
Evolution of tumours and the impact of molecular oncology. Nature (1985) 4.24
Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science (1983) 3.82
Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells. Cell (1984) 3.66
Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (1984) 3.48
A reproducible microanalytical method for the detection of specific RNA sequences by dot-blot hybridization. Anal Biochem (1984) 3.47
Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science (1983) 3.40
Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature (1984) 3.09
Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem (1983) 2.97
Close link between reduction of c-myc expression by interferon and, G0/G1 arrest. Nature (1985) 2.47
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci U S A (1985) 2.24
Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells. Proc Natl Acad Sci U S A (1983) 1.73
Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell (1986) 1.73
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. Proc Natl Acad Sci U S A (1984) 1.65
Identity of differentiation inducing factor and tumour necrosis factor. Nature (1986) 1.50
Chromatin structure around the c-myc gene in Burkitt lymphomas with upstream and downstream translocation points. Proc Natl Acad Sci U S A (1985) 1.47
Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells. EMBO J (1984) 1.31
Monoclonal antibodies to human alpha-interferon and their use for affinity chromatography. J Immunol (1982) 1.30
Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science (1986) 1.30
Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend erythroleukemia cells. Mol Cell Biol (1982) 1.21
Genetic suppression of tumor formation: a new frontier in cancer research. Cancer Res (1986) 1.19
Increased levels of (2'-5')oligo(A) polymerase activity in human lymphoblastoid cells treated with glucocorticoids. Proc Natl Acad Sci U S A (1980) 1.19
Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 0.98
Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance. Mol Cell Biol (1986) 0.90
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. J Natl Cancer Inst (1982) 0.83
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. J Natl Cancer Inst (1982) 0.79
Proliferation inhibitory effect of human alpha interferon on primary explants of Burkitt lymphoma: inverse relationship to patient survival. Biomedicine (1981) 0.77
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
Close link between reduction of c-myc expression by interferon and, G0/G1 arrest. Nature (1985) 2.47
Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell (1986) 1.73
Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. Science (1988) 1.72
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). J Natl Cancer Inst (1980) 1.53
G1 control in mammalian cells. J Cell Sci Suppl (1994) 1.34
Increasing empathy among medical students. Med Educ (1989) 1.27
Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene (1996) 1.15
A new cryosurgical device for controlled freezing. Cryobiology (1996) 1.10
Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Oncogene (1997) 1.06
Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochem Biophys Res Commun (1989) 1.03
Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene (1997) 1.03
Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol (1996) 1.02
Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 0.98
Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase. EMBO J (1994) 0.95
Extinction of expression of immunoglobulin genes in myeloma X fibroblast somatic cell hybrids. Mol Cell Biol (1987) 0.95
Impact of workshop on students' and physicians' rejecting behaviors in patient interviews. J Med Educ (1987) 0.94
Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int J Cancer (1978) 0.91
Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. J Immunol (1988) 0.90
Proof of in vivo fusion of murine tumor cells with host cells by universal fusers. J Natl Cancer Inst (1978) 0.87
Autocrine interferon and the suppression of the c-myc nuclear oncogene. Interferon (1987) 0.85
An evaluation of the short-term effects of an interpersonal skills course. Med Educ (1984) 0.84
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. J Natl Cancer Inst (1982) 0.83
Cell cycle events in the hydrocortisone regulation of alkaline phosphatase in HeLa S3 cells. J Cell Biol (1969) 0.82
Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative. Cell Growth Differ (1993) 0.81
Changes in p53 mRNA expression during terminal differentiation of murine erythroleukemia cells. Virology (1987) 0.80
Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men. J Nucl Med (1990) 0.80
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. J Natl Cancer Inst (1982) 0.79
Extinction of expression of the translocated myc gene in somatic cell hybrids between mouse myeloma and L-cells. Int J Cancer (1989) 0.79
Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid. J Natl Cancer Inst (1982) 0.78
Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells. Ann Hum Genet (1981) 0.78
Use of isolated mitochondria to transfer chloramphenicol resistance in hamster cells. Isr J Med Sci (1984) 0.77
The teaching of history-taking and diagnostic thinking: description of a method. Med Educ (1981) 0.77
Membrane-bound and cellular immunoglobulins in human B-lymphoma lines and derived hybrids. Immunobiology (1981) 0.77
Fusion of plasmacytoma and host cells in vivo: selection of proliferating and nonproliferating cultures. J Natl Cancer Inst (1984) 0.76
Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids. Somat Cell Mol Genet (1996) 0.76
Viral expression and immunogenicity of CBA mammary carcinomas and their hybrid lines with an L-cell derivative (A9HT). Eur J Cancer (1979) 0.76
Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Int J Cancer (1978) 0.76
Effect of plasmacytoma cells on the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) in the spleen of tumor-bearing mice. Exp Hematol (1987) 0.75
Carp growth hormone: molecular cloning and sequencing of cDNA. Gene (1989) 0.75
Cell surface antigen expression in cytoplasts and karyoplasts of mouse L cells. Cancer Lett (1978) 0.75
Phenotypic trait transferred by cybridization. Cytogenet Cell Genet (1978) 0.75
Prolactin and MA-10 Leydig cell steroidogenesis: biphasic effects of prolactin and signal transduction. Endocrinology (1996) 0.75
Isolation of ouabain-resistant human lymphoblastoid cell lines by multi-step selection. Mutat Res (1979) 0.75
Consistent patterns of changing hormone responsiveness during continuous culture of cloned rat calvaria cells. J Bone Miner Res (1988) 0.75
Decay of Moloney leukemia virus production after enucleation of chronically infected mouse cells. Isr J Med Sci (1981) 0.75
Production of ascites and rescue of hybridomas by intrasplenic inoculation. Methods Enzymol (1986) 0.75
[Objective structured clinical examination: a tool for evaluation and for teaching]. Harefuah (1990) 0.75
Doctor-patient relationship and the medical student: the use of trigger films. J Med Educ (1982) 0.75
Prolactin and testicular Leydig cell function: characterization of prolactin receptors in the murine MA-10 testicular Leydig cell line. Proc Soc Exp Biol Med (1994) 0.75
[Fusion of tumor with host cells in vivo]. Harefuah (1984) 0.75
Structured skill test in physical examination. Psychol Rep (1981) 0.75
Absence of negative growth regulation in three new murine radiation-induced myeloid leukemia cell lines with deletion of chromosome 2. Leukemia (1992) 0.75
Restriction of C-type viral antigen in H-2/Fv-1 syngeneic mouse somatic cell hybrids. Intervirology (1980) 0.75
Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice. J Natl Cancer Inst (1983) 0.75
The concentration of bleomycin labeled with Co-57 in primary and metastatic tumors. Cancer (1989) 0.75
Reduction of c-myc expression by IFN: further analysis of the sensitive and the resistant phenotype of cells. Prog Clin Biol Res (1985) 0.75
Subclone heterogeneity in a clonally-derived osteoblast-like cell line. Bone (1985) 0.75
Cloning of plasmacytoma micrometastases from spleen. J Immunol Methods (1985) 0.75
Truncated mu chain in a Burkitt lymphoma line (P3HR-1) and its fate in various hemapoietic somatic cell hybrids. Immunobiology (1982) 0.75
Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity. Int J Cancer (1982) 0.75
Suppression of the translocated myc gene and expression of intracisternal A-particle genes in tumorigenic and non-tumorigenic hybrids between murine myeloma and normal fibroblasts. Int J Cancer (1991) 0.75
Characterization and regulation of prolactin receptors in MA-10 Leydig cells. Mol Cell Endocrinol (1998) 0.75
[Who will care for medical professionalism in Israel?]. Harefuah (2001) 0.75